Article information
Resumen
Los autores experimentan diversos regímenes antituberculosos basados en la acción de la rifampicina.
De acuerdo con la experiencia obtenida los regímenes bisemanales son tan eficaces como los diarios y la incidencia de fenómenos tóxicos es semejante. No existen diferencias en la eficacia terapéutica de los regímenes con drogas similares realizados dos o tres veces por semana.
Los autores han empleado como drogas: hidracidas, rifampicina y etambutol.
Summary
The authors have experimented with various anti-tuberculosis regimens based on the action of rifampicina.
According to their obtained experience, biweekly regimens are as effective as daily regimens and the incidence of toxic phenomena is similar. There are no differences in the therapeutic effectiveness of regimens with similar drugs carried out two or three times weekly.
The authors have used as drugs: hydracids, rifampicina and ethambutol.
Full text is only aviable in PDF
Bibliografía
[1.]
Kreis, B.: Traitements intermittents. XVI Congrés National de la Tuberculose et des maladies respiratoires. Ed. Masson, p. 228.
[2.]
British medical research council madras.
Various combinations of isoniazid with streptomycin or with PAS in the treatment of pulmonary tuberculosis.
Brit.med.J., 1 (1955), pp. 435
[3.]
Tuberculosis chemotherapy centre madras.
A concurrent comparison of intermittent (Twice-WeekIy) isionazid plus streptomycin and daily isionazid plus PAS in the domiciliary treatment of pulmonary tuberculosis.
Bitll. Wld. Hith. Og., 31 (1964), pp. 274
[4.]
S.P. Tripathy.
L’étude de Madras sur la chimiothérapie órale intermitiente. XXI Conférence Internationale de la Tuberculose.
Bull. Un. Int. Tubero., 47 (1972), pp. 32
[5.]
N.K. Menon.
Madras study of two once weekiy regimes. Clinical aspects. XX Conférence internationale de la Tuberculose.
Bull. Un. Int. Tuberc., 43 (1970), pp. 271
[6.]
M. Grumbach.
Further experiments on long-term chemotherapy of advanced murine tuberculosis, with emphasis on intermittent regimes.
Tuberde (Edinb.), 45 (1964), pp. 125
[7.]
J.M. Dickinson, G.A. Ellard, D.A. Mitchison.
Suitability of isionazid and ethambutol for intermittent administration in the treantment of tuberculosis.
Tubercle (Edinb.)., 49 (1968), pp. 351
[8.]
S. Dickinson, D. Mitchinson.
Suitability of rifampicin for intermitten administration in the treatment of tuberculosis.
Tubercle (Edinb.), 51 (1970), pp. 80
[9.]
L. Verbist.
Experimentelle Grundlage der Intermitterenden Behandlung. Neue Wege der Tuberkulosetherapie. Viena, 1970.
Pneumol, 31 (1970),
[10.]
W. Fox.
The John Barnwell lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.
Am. Rev. Resp Bis, 97 (1968), pp. 767
[11.]
J. March Ayuela.
Resultados lejanos de la quimioterapia estandard. Revisión de 194 enfermos observados entre cinco y nueve años.
Enferm. Tórax, 83 (1972), pp. 431
[12.]
D. Larbaqui, K. Abderrahim.
Le tratement bihébdomadaire de la tuberculose pulmonaire par isoniazide et streptomycine avec ou sans phase continué inítiale. Résultats obtenus a Alger.
Rev. Tuberc, 32 (1968), pp. 393
[13.]
W. Fox.
Considérations générales sur le choix et le maniement des régimes thérapeutiques dans la tuberculose pulmonaire. XXI Conférence Internationale de la Tuberculose.
Bull. Un. Int. Tuberc., 47 (1972), pp. 51
[14.]
A comparative study of daily and twiceweekly continuation regimens of tuberculosis chemotherapy including a comparison of two durations of sanatorium treatment: flrst report: the results at 12 months..
WHO collaborating centre tuberculosis chemotherapy (Prague).
Bull Wld. Olth. Org., 45 (1971), pp. 573
[15.]
S. Larbaqui.
Etude controléé d’un traitement bihébdomadaire par isoniazide et ethionamide. XX Conférence Internationale de la Tuberculose. tull.
Un. Int. Tuberc., 43 (1970), pp. 282
[16.]
L. Sbarbaro.
Tuberculous chemotherapy for recalcitrant outpatients administered directly twice weekly.
Am. Rev. Res. Dis., 97 (1968), pp. 895
[17.]
M. Poole, P. Strandling.
Intermittent chemotherapy for tuberculosis in an urban community.
Brit. med. J., 1 (1969), pp. 82
[18.]
L. Larbaqui.
Retreatment of pulmonary tuberculosis with intermittent regimes of rifampicin and ethambutol.
Acta, tuberc. pneumol. belg., 62 (1971), pp. 326
[19.]
M. Zierski.
Retreatment of cronic pulmonary tuberculosis with intermittent rifampicin-combined regimes.
Acta, tuberc. pneumol. belg., 62 (1971), pp. 320
[20.]
M. Zierski.
Intermittierende Chemotherapie der Lungentuberkulose.
Prax. pneumol., 28 (1974), pp. 263
[21.]
S. Doyle.
Primary treatment of pulmonary tuberculosis with rifampicin.
Acta tuber. pneumol. belg., 62 (1971), pp. 323
[22.]
I. Verbist, P. Gyselen.
Intermittent therapy with rifampicin once a week in avanced pulmonary tuberculosis.
Acta. Pneumol. belg., 62 (1971), pp. 324
[23.]
H. Eule.
Bacteriologic results and sideeffects of a once weekly regimen containing rifampicin and isoniazid in high dosage.
Acta, tuberc. pneumol. belg., 62 (1971), pp. 325
[24.]
D. Pilfieu.
Tratamiento intermitente de la tuberculosis pulmonar inicial con ethambutol-isoniazida.
Rev. arqent. tuberc., 33 (1972), pp. 11
[25.]
J. Belenguer, E. Hernandez, A. Ortega.
Los regímenes discontinuos enla terapéutica de la tuberculosis pulmonar abierta del adulto.
Enferm. Tórax, 86 (1973), pp. 305
[26.]
F. Dubra.
Essaie thérapeutique controlé avec l’association rifampicine-sioniazide administrée pendant six mois chez les tuberculeux pulmonaires non traités auparavant. XXI Conférence Internationale de la Tuberculose.
Bull. Un. int. tuberc., 43 (1972), pp. 39
[27.]
J. Gomi.
Intermittent rifampicin regimens in retratment of pulmonary tuberculosis.
Acta, tuberc. pneumol. belg., 313 (1971),
[28.]
M. Silveira.
Intermittent treatment with rifampicin and isoniazid in pulmonary tuberculosis.
Acta, tuberc. pneumol. belg., 314 (1971),
[29.]
G. Decroix, L. Pujet.
Effects collatéraux systemiques des traitements antituberculeux intermittents par la rifampicine.
Rev. Tuberc., 35 (1971), pp. 733
[30.]
A. Sors, S. Sarrazin, M. Homberg.
Accidents hemolytiques récidivants d’origine inmuno-allergique au cours d’un traitement intermittent par la rifampicine.
Rev. Tuberc., 36 (1972), pp. 405
[31.]
A. Ortega, J. Belenguer, E. Hernandez.
Efectos tóxicos de la rifampicina en la politerapia de la tuberculosis pulmonar abierta del adulto.
Enferm. Tórax, 83 (1972), pp. 383
[32.]
M. Zierski.
Systemic side-effects under continuing intermittent treatment rifampicin.
Acta, tuberc. pneumol. belg., 62 (1971), pp. 321
[33.]
M. Poole, P. Stradling, G. Worlledge.
Side-effects on intermittent treatment with rifampicin.
Acta, tuberc. pneumol. belg., 62 (1971), pp. 320
[34.]
Farga, J.: Comunicación personal.
Copyright © 1976. Sociedad Española de Neumología y Cirugía Torácica
